Gross Profit for Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's current gross profit (TTM) is $14.52B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$14.52B
YoY change
+34.9%
5Y CAGR
+20.0%
Peak year (2025)
$13.85B
Cumulative gross profit
$151.77B
Gross Profit history chart for Boston Scientific (BSX) from 1991 to 2025
Gross Profit history table for Boston Scientific (BSX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $13.85B | +34.9% | ||
| 2024 | $10.27B | +16.3% | ||
| 2023 | $8.83B | +14.5% | ||
| 2022 | $7.71B | +3.4% | ||
| 2021 | $7.46B | +33.8% | ||
| 2020 | $5.58B | -18.9% | ||
| 2019 | $6.88B | +6.2% | ||
| 2018 | $6.48B | +10.3% | ||
| 2017 | $5.87B | +9.9% | ||
| 2016 | $5.34B | +17.1% | ||
| 2015 | $4.56B | -0.5% | ||
| 2014 | $4.59B | +1.2% | ||
| 2013 | $4.54B | -0.5% | ||
| 2012 | $4.56B | -2.6% | ||
| 2011 | $4.68B | -2.2% | ||
| 2010 | $4.79B | -7.5% | ||
| 2009 | $5.18B | +1.7% | ||
| 2008 | $5.09B | -5.7% | ||
| 2007 | $5.40B | +6.2% | ||
| 2006 | $5.08B | +7.1% | ||
| 2005 | $4.75B | +10.9% | ||
| 2004 | $4.28B | +70.1% | ||
| 2003 | $2.52B | +22.7% | ||
| 2002 | $2.05B | +16.8% | ||
| 2001 | $1.75B | -8.7% | ||
| 2000 | $1.92B | -1.0% | ||
| 1999 | $1.94B | +23.3% | ||
| 1998 | $1.57B | +11.8% | ||
| 1997 | $1.41B | +25.5% | ||
| 1996 | $1.12B | +35.2% | ||
| 1995 | $830.00M | +180.6% | ||
| 1994 | $295.80M | +20.1% | ||
| 1993 | $246.20M | +21.1% | ||
| 1992 | $203.30M | +34.1% | ||
| 1991 | $151.60M | — |
Gross Profit values are taken from Boston Scientific's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Boston Scientific (BSX) gross profit totalled $13.85B – surged 34.9% year-over-year.
Over 2020–2025 (5 years), Boston Scientific gross profit expanded at a +20.0% compound annual rate, sustaining 5 straight years of year-over-year growth.
$13.85B stands as the all-time-high annual gross profit, posted in 2025, against a low of $151.60M during 1991.
Among 8 Healthcare peers, Boston Scientific (BSX) ranks 9th; the peer median for gross profit is $53.80B.
Boston Scientific Gross Profit by Year
Boston Scientific Gross Profit 2025: $13.85B
Boston Scientific gross profit in 2025 was $13.85B, surged 34.9% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Gross Profit 2024: $10.27B
Boston Scientific gross profit in 2024 was $10.27B, grew 16.3% from 2023.
Boston Scientific Gross Profit 2023: $8.83B
Boston Scientific gross profit in 2023 was $8.83B, grew 14.5% from 2022.
Boston Scientific Gross Profit 2022: $7.71B
Boston Scientific gross profit in 2022 was $7.71B, edged up 3.4% from 2021.
Boston Scientific Gross Profit 2021: $7.46B
Boston Scientific gross profit in 2021 was $7.46B.
See more financial history for Boston Scientific (BSX).
Sector peers — Gross Profit
Companies in the same sector as Boston Scientific, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is Boston Scientific's gross profit?
- Latest reported gross profit for Boston Scientific (BSX) is $14.52B (period ending March 31, 2026).
How has Boston Scientific gross profit changed year-over-year?
- Boston Scientific (BSX) gross profit changed +34.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Boston Scientific gross profit?
- Boston Scientific (BSX) gross profit compound annual growth rate is +20.0% over the most recent 5 years available.
When did Boston Scientific gross profit hit its highest annual value?
- Boston Scientific gross profit reached its highest annual value of $13.85B in 2025.
What was Boston Scientific gross profit in 2024?
- Boston Scientific (BSX) gross profit in 2024 was $10.27B.
What was Boston Scientific gross profit in 2025?
- Boston Scientific (BSX) gross profit in 2025 was $13.85B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BSX Overview
Company profile, financial tools, and key metrics
BSX Revenue Counter
Earns $653.70 every second. See per minute, hour, and day.
BSX Earnings Counter
Earns $112.66 per second net profit. See per minute, hour, and day.
BSX Economic Scale
Exceeds Niger's GDP. Compare with world economies.
BSX What If Invested
What if you had invested $1,000? See historical returns from any date.
BSX How It Makes Money
Discover visual breakdown of $20.61B in revenue — where it comes from and where it goes.
BSX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BSX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BSX Daily Price Character
Balanced · 48.8% historical win rate (green days). Streaks & record days.
BSX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BSX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.